... biopharmaceutical company's stock worth $580,000 after purchasing an additional 104,038 shares in the last quarter. Ardsley Advisory Partners raised its position in Abeona Therapeutics by 33.3% in the second quarter. Ardsley Advisory Partners now ...
http://ift.tt/2yKGe5I
No comments:
Post a Comment